Expression of functional protease-activated receptor 1 in human prostate cancer cell lines
- 25 March 2003
- journal article
- research article
- Published by Springer Nature in Urological Research
- Vol. 31 (3) , 163-168
- https://doi.org/10.1007/s00240-003-0309-2
Abstract
Functional protease-activated receptors (PAR) are expressed by a variety of malignant cells. In the present study, RT-PCR assays demonstrated the expression of the thrombin receptor PAR-1 mRNA in human prostate cancer cell lines DU 145, LnCAP, and SV40-immortalized human prostate epithelial cell line PNT1A. In contrast, the additional thrombin receptors PAR-3 and PAR-4 were not detected. PAR-1 protein localized to the cellular surface was detected by flow cytometry in all three cell lines. To demonstrate the functional importance of the PAR-1, the effects of different concentrations of thrombin on cell proliferation kinetics were assessed. The treatment of growth-arrested cells with varying concentrations of thrombin demonstrated dose- and time-dependent effects. At low concentration (<0.5 U/ml), thrombin induced proliferation of all prostate-derived cell lines. Thrombin at higher concentration (1.0 U/ml) initially stimulated PNT1A and LnCAP cells to proliferate (time of thrombin application 24 h and 48 h) followed by inhibited growth when assessed after 72 h of incubation. In contrast, 1.0 U/ml thrombin caused earlier inhibition of DU 145 proliferation starting at 48 h of incubation. Our results suggest that PAR-1 mediates the proliferation-modulating effects of thrombin on prostate cancer cells.Keywords
This publication has 36 references indexed in Scilit:
- Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.2001
- Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells.2000
- Expression of Prothrombin Fragment 1+2 in Cancer Tissue as an Indicator of Local Activation of Blood CoagulationThrombosis Research, 2000
- Calcium signals in prostate cancer cells: specific activation by bone-matrix proteinsCell Calcium, 2000
- EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGFNature, 1999
- Thrombomodulin expression in transitional cell carcinoma.American Journal of Clinical Pathology, 1998
- Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumour tyrosine phosphorylationBritish Journal of Haematology, 1996
- Thrombin stimulates melanoma tumor‐cell binding to endothelial cells and subendothelial matrixInternational Journal of Cancer, 1993
- Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo.1992
- D-PHE-PRO-ARGCH2Cl-A selective affinity label for thrombinThrombosis Research, 1979